Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDWRH Networking Events 2022

Welcome to the NDWRH Networking Events Microsite. During 2022, our department will host 4 networking events at St. Anne's College. Each event will centre around one of the four overarching NDWRH research themes, Maternal & Fetal Health (6th May), Global Health (13th May), Reproductive Medicine & Genetics (27th May) and Cancer (7th June). The objective of these events are to have focussed theme specific discussions and to foster collaborations with other research groups where synergies exist. On this site you can view PI research summary slides (where available) from our department's PI Planning day in 2021. They are displayed by our Women's Health research themes: Maternal and Fetal Health, Global Health, Reproductive Medicine & Genetics and Cancer.

  • Krina Zondervan
    Krina Zondervan

    Head of Department, Professor of Reproductive & Genomic Epidemiology, Co-Director Endometriosis CaRe Centre.

Maternal and Fetal Health Event - 6th May

Lactation

University of Oxford Initiates Research on Endocrinology of Human Lactation

PI Fadil Hannan

Imaging in Fetal Health

Our research on Intelligent Imaging in Fetal Health is led by Prof Aris Papageorghiou. It encompasses two key areas; Pregnancy Imaging Laboratory and Global Maternal and Fetal Health.

PI Aris Papageorghiou

OSPREA & Gynae

The Nuffield Department of Women's & Reproductive Health sought and obtained ethical approval to allow the medical records (including clinical data, ultrasound images and fetal heart traces) of all mothers and babies to be used anonymously and confidentially to monitor and improve the quality of the maternity services, and help research into the causes of pregnancy‐related problems. That approval has since been extended to include hospitals in the Oxford Academic Health Science Maternity Network. Please contact us to discuss the studies you may be eligible for and answer any questions you may have.

Ginny Mounce & Tabitha Wishlade 

Oxford Labour Monitoring

Oxford Labour Monitoring logo

PI Antoniya Georgieva

Placental Imaging

The placenta is the most indispensable, disposable organ you ever had. It decrees both how well we grow and develop in the womb and our future health well into adulthood. Our research explores two key themes: 1) Imaging the placenta early in pregnancy in order to predict adverse pregnancy outcomes including fetal growth restriction and 2) Diagnosis and management of Placenta Accreta Spectrum Disorder (PAS) - also known as abnormally invasive placenta (AIP).

PI Sally Collins

Preeclampsia

Pre-eclampsia affects some pregnant women, usually during the second half of pregnancy (from around 20 weeks) or soon after their baby is delivered.

PI Manu Vatish

Global Health Event - 13th May

Cardiovascular Disease

Cardiovascular Disease

PI Kazem Rahimi

See research webpage

ME/CFS

Morten Group

PI Karl Morten

OMPHI

Oxford Maternal & Perinatal Health Institute (OMPHI)

PI Aris Papageorghiou 

See research webpage

SMARThealth Pregnancy

Our department includes The George Institute for Global Health UK (TGI). They seek to challenge the status quo in healthcare to find the best ways to prevent and treat non-communicable diseases (NCDs) and injury, and to influence policy and practice worldwide. A recent project is SmartHealth Pregnancy - a tablet-based clinical decision support system in antenatal and postnatal care for use by rural healthcare workers in India.

PI Jane Hirst

Reproductive Medicine and Genetics Event - 27th May

Endometriosis Care

Endometriosis affects up to 1 in 10 women during their reproductive years between the ages of 15 to 49, which is approximately 176 million women in the world. The condition is defined as the presence of tissue resembling the uterine lining outside of the uterine cavity. Typical symptoms include painful periods, painful ovulation, pain during or after sex, abnormal bleeding, chronic pelvic pain, fatigue, and infertility, and it can also impact on general physical, mental and social well-being.

PIs Christian Becker & Krina Zondervan

Miscarriage

Miscarriage

PIs Ingrid Granne & Jen Southcombe

Mitochondria

Digital illustration of Mitochondria

PI Jo Poulton

Oocytes and Ovaries

Oocytes and ovaries

PI Suzannah Williams

Pain in women

Pain in Women

PI Katy Vincent

BDI Groups

PIs Cecilia Lindgren, Mike Suttie ​and Chris Nellaker​

Cancer Event - 7th June

Cervical Neoplasia

Congratulations to our OSPREA-Gynae team as the first UK participant in the HPV0001 trial received the first dose of their vaccine on 5th July 2021. HPV001 is investigating the broadest therapeutic vaccine to show efficacy against cervical abnormalities associated with 5 high-risk HPV types and is a randomised, double-blind, placebo-controlled study involving 15 trial sites across the UK and Europe, with Oxford as the lead trial site.

PI Karin Hellner

Nanoparticles in Cancer

Cancer small

PI Helen Townley

See research webpage